Market Cap 3.64M
Revenue (ttm) 110,000.00
Net Income (ttm) -14.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13,336.36%
Debt to Equity Ratio 0.00
Volume 63,600
Avg Vol 804,842
Day's Range N/A - N/A
Shares Out 1.70M
Stochastic %K 5%
Beta 1.13
Analysts Strong Buy
Price Target $64.83

Latest News on ONVO

Organovo Provides Business Update

Mar 27, 2025, 8:05 AM EDT - 8 days ago

Organovo Provides Business Update


Organovo Announces Reverse Stock Split

Mar 19, 2025, 8:05 AM EDT - 16 days ago

Organovo Announces Reverse Stock Split


Organovo Announces FXR Program

Mar 21, 2023, 8:05 AM EDT - 2 years ago

Organovo Announces FXR Program


Organovo Achieves 3D Tissue Model for Crohn's Disease

May 17, 2022, 8:05 AM EDT - 3 years ago

Organovo Achieves 3D Tissue Model for Crohn's Disease


Catherine Wood's ARK Investment Slashes Organovo Holding

Mar 11, 2021, 3:58 PM EST - 4 years ago

Catherine Wood's ARK Investment Slashes Organovo Holding


Organovo Announces One-for-Twenty Reverse Stock Split

Aug 17, 2020, 8:05 AM EDT - 5 years ago

Organovo Announces One-for-Twenty Reverse Stock Split


Organovo Acknowledges Receipt of Proposal

Oct 2, 2019, 7:31 PM EDT - 5 years ago

Organovo Acknowledges Receipt of Proposal